EDQM issued CEP Certificate for MESALAZINE

European Directorate for the Quality of Medicines & Health Care ("EDQM") has issued a Certificate of Suitability for "MESALAZINE" on 16th January 2025. This certification will enable IOL Chemicals and Pharmaceuticals Limited to export this product in European and other CEP accepting countries. Mesalazine is used to treat inflammatory bowel disease.

Shares of IOL Chemicals and Pharmaceuticals Limited was last trading in BSE at Rs. 389.60 as compared to the previous close of Rs. 391.95. The total number of shares traded during the day was 11610 in over 600 trades.

The stock hit an intraday high of Rs. 391.95 and intraday low of 386.95. The net turnover during the day was Rs. 4520793.00.

Source : Equity Bulls

Keywords

IOLChemicalsandPharmaceuticals INE485C01011 EDQM CEP Mesalazine